These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9087872)

  • 1. Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis.
    Park JW; Merz M; Braun P
    J Heart Lung Transplant; 1997 Mar; 16(3):290-7. PubMed ID: 9087872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
    Sosland RP; Gollub SB; Wilson DB; Moriarty PM
    Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of transplant coronary artery disease during chronic HELP therapy: a case study.
    Park JW; Vermeltfoort M; Braun P; May E; Merz M
    Atherosclerosis; 1995 May; 115(1):1-8. PubMed ID: 7669080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
    Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
    J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.
    Safarova MS; Ezhov MV; Afanasieva OI; Matchin YG; Atanesyan RV; Adamova IY; Utkina EA; Konovalov GA; Pokrovsky SN
    Atheroscler Suppl; 2013 Jan; 14(1):93-9. PubMed ID: 23357149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
    Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
    Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
    Schuff-Werner P
    Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term effect of LDL apheresis on coronary heart disease.
    Donner MG; Richter WO; Schwandt P
    Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit in heart transplant recipients who have coronary artery disease confirmed using angiography and are receiving sirolimus.
    Zakliczynski M; Swierad M; Nozynski J; Maruszewski M; Zembala M
    Transplant Proc; 2009; 41(1):285-8. PubMed ID: 19249536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian multicenter study on low-density lipoprotein apheresis Working Group 2009 survey.
    Stefanutti C; Morozzi C; Di Giacomo S;
    Ther Apher Dial; 2013 Apr; 17(2):169-78. PubMed ID: 23551673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of restenosis after coronary angioplasty with low-density lipoprotein apheresis.
    Adachi H; Niwa A; Shinoda T
    Artif Organs; 1995 Dec; 19(12):1243-7. PubMed ID: 8967882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation.
    Schuff-Werner P; Gohlke H; Bartmann U; Baggio G; Corti MC; Dinsenbacher A; Eisenhauer T; Grützmacher P; Keller C; Kettner U
    Eur J Clin Invest; 1994 Nov; 24(11):724-32. PubMed ID: 7890009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.